102 related articles for article (PubMed ID: 3002268)
1. Comparison of arildone and 3-methylquercetin as stabilizers of poliovirus.
Rombaut B; Vrijsen R; Boeye A
Antiviral Res; 1985; Suppl 1():67-73. PubMed ID: 3002268
[No Abstract] [Full Text] [Related]
2. Action of 3-methylquercetin on poliovirus RNA replication.
Castrillo JL; Carrasco L
J Virol; 1987 Oct; 61(10):3319-21. PubMed ID: 2442414
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of flavones and potentiation by ascorbate.
Vrijsen R; Everaert L; Boeyé A
J Gen Virol; 1988 Jul; 69 ( Pt 7)():1749-51. PubMed ID: 2839607
[TBL] [Abstract][Full Text] [Related]
4. Lack of evidence for strand-specific inhibition of poliovirus RNA synthesis by 3-methylquercetin.
Lopez Pila JM; Kopecka H; Vanden Berghe D
Antiviral Res; 1989 Feb; 11(1):47-53. PubMed ID: 2540709
[TBL] [Abstract][Full Text] [Related]
5. Antipoliovirus flavonoids from Psiadia dentata.
Robin V; Irurzun A; Amoros M; Boustie J; Carrasco L
Antivir Chem Chemother; 2001 Sep; 12(5):283-91. PubMed ID: 11900347
[TBL] [Abstract][Full Text] [Related]
6. The poliovirus-induced shut-off of cellular protein synthesis persists in the presence of 3-methylquercetin, a flavonoid which blocks viral protein and RNA synthesis.
Vrijsen R; Everaert L; Van Hoof LM; Vlietinck AJ; Vanden Berghe DA; Boeyé A
Antiviral Res; 1987 Jan; 7(1):35-42. PubMed ID: 3026245
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of 3-methoxyflavones.
Vlietinck AJ; Vanden Berghe DA; Van Hoof LM; Vrijsen R; Boeyé A
Prog Clin Biol Res; 1986; 213():537-40. PubMed ID: 3012584
[No Abstract] [Full Text] [Related]
8. Effect of arildone on modifications of poliovirus in vitro.
Caliguiri LA; McSharry JJ; Lawrence GW
Virology; 1980 Aug; 105(1):86-93. PubMed ID: 6251614
[No Abstract] [Full Text] [Related]
9. Inhibition of uncoating of poliovirus by arildone, a new antiviral drug.
McSharry JJ; Caliguiri LA; Eggers HJ
Virology; 1979 Sep; 97(2):307-15. PubMed ID: 224584
[No Abstract] [Full Text] [Related]
10. 3-Methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis.
Castrillo JL; Vanden Berghe D; Carrasco L
Virology; 1986 Jul; 152(1):219-27. PubMed ID: 3012868
[TBL] [Abstract][Full Text] [Related]
11. Isolation of poliovirus variants resistant to and dependent on arildone.
Schrom M; Laffin JA; Evans B; McSharry JJ; Caliguiri LA
Virology; 1982 Oct; 122(2):492-7. PubMed ID: 6293183
[No Abstract] [Full Text] [Related]
12. Effects of arildone on the immunogenicity of formalin-inactivated polioviruses.
Abe S; Yamaki A; Doi Y; Yoshioka I
Jpn J Med Sci Biol; 1987 Feb; 40(1):1-13. PubMed ID: 3041077
[TBL] [Abstract][Full Text] [Related]
13. Poliovirus infection without accumulation of eclipse particles.
Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
Antiviral Res; 1995 Jan; 26(1):27-35. PubMed ID: 7741519
[TBL] [Abstract][Full Text] [Related]
14. Proteolysis of the p220 component of the cap-binding protein complex is not sufficient for complete inhibition of host cell protein synthesis after poliovirus infection.
Bonneau AM; Sonenberg N
J Virol; 1987 Apr; 61(4):986-91. PubMed ID: 3029432
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence spectrophotometric study of structural alterations in the capsid of poliovirus.
Grimmel M; Zibirre R; Koch G
Arch Virol; 1983; 78(3-4):191-201. PubMed ID: 6318693
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiviral activity of 7-O-(omega-substituted)-alkyl-3-O-methylquercetin derivatives.
Boers F; Lemiere G; Lepoivre JA; De Groot A; Dommisse R; De Bruyne T; Vlietinck AJ; Vanden Berghe DA
Pharmazie; 1998 Aug; 53(8):512-7. PubMed ID: 9741060
[TBL] [Abstract][Full Text] [Related]
17. Eclipse products of poliovirus after cold-synchronized infection of HeLa cells.
Everaert L; Vrijsen R; Boeyé A
Virology; 1989 Jul; 171(1):76-82. PubMed ID: 2545039
[TBL] [Abstract][Full Text] [Related]
18. Quercetinase pirin makes poliovirus replication resistant to flavonoid quercetin.
Neznanov N; Kondratova A; Chumakov KM; Neznanova L; Kondratov R; Banerjee AK; Gudkov AV
DNA Cell Biol; 2008 Apr; 27(4):191-8. PubMed ID: 18067462
[TBL] [Abstract][Full Text] [Related]
19. In vitro assembly of poliovirus 14 S subunits: disoxaril stabilization as a model for the antigenicity conferring activity of infected cell extracts.
Rombaut B; Boeyé A
Virology; 1991 Feb; 180(2):788-92. PubMed ID: 1703372
[TBL] [Abstract][Full Text] [Related]
20. Effect of flavonoids and related substances. II. Antiviral effect of quercetin, dihydroquercetin and dihydrofisetin.
Bakay M; Mucsi I; Béládi I; Gábor M
Acta Microbiol Acad Sci Hung; 1968; 15(3):223-7. PubMed ID: 4305448
[No Abstract] [Full Text] [Related]
[Next] [New Search]
